Close Menu
Home » Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction

Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction

Dec 05, 2019
|
Christie Rizk
Premium

NEW YORK – Researchers at Massachusetts General Hospital, Color, and elsewhere have determined that polygenic factors can significantly modify the risk conferred by monogenic risk variants for breast cancer, colon cancer, or coronary artery disease, and are exploring the best ways to implement a combined monogenic/polygenic risk score into patient care.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Genetic Research

  1. Rare CNVs Associated With Major Disease Categories in Large Study of European Subjects

  2. Presence of B Cells in Tumors Associated With Favorable Immunotherapy Outcomes

  3. Asthma Drug Resistance Linked to Variant in Androgen Synthesis Gene

  4. Study Identifies Loci Associated With Alcohol Consumption, Explores Links to Other Conditions

  5. Genomic Analysis Elucidates Settlement of Brazilian Coast by Indigenous Peoples

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.